|
BR6915369D0
(pt)
|
1969-02-27 |
1973-03-13 |
Bayer Ag |
Emprego de inibidores biologicos de proteases para conservacao de orgaos tecidos e alimentos
|
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
DE2619246A1
(de)
|
1976-04-30 |
1977-11-10 |
Bayer Ag |
Desamino-derivate des kallikrein- trypsin-inhibitors, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
DE2654124A1
(de)
|
1976-11-29 |
1978-06-01 |
Bayer Ag |
Derivate des trypsin-kallikrein-inhibitors aus rinderorganen (bpti) mit proteasenhemmwirkung und antiphlogistischer wirkung, ihre herstellung und ihre verwendung als arzneimittel
|
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
AT359653B
(de)
*
|
1979-02-15 |
1980-11-25 |
Immuno Ag |
Verfahren zur herstellung eines gewebekleb- stoffes
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
AU560584B2
(en)
|
1983-07-28 |
1987-04-09 |
Bayer Aktiengesellschaft |
Homologues of aprotinin
|
|
US4657893A
(en)
|
1984-05-09 |
1987-04-14 |
Syntex (U.S.A.) Inc. |
4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors
|
|
US4845242A
(en)
|
1987-04-28 |
1989-07-04 |
Georgia Tech Research Corporation |
Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
|
|
US4609725A
(en)
|
1984-10-09 |
1986-09-02 |
Merck & Co., Inc. |
Cardiac atrial peptides
|
|
US4931385A
(en)
*
|
1985-06-24 |
1990-06-05 |
Hygeia Sciences, Incorporated |
Enzyme immunoassays and immunologic reagents
|
|
US5444156A
(en)
*
|
1985-07-12 |
1995-08-22 |
Temple University-Of The Commonwealth System Of Higher Education |
Monoclonal antibodies to human plasma prekallikrein
|
|
JPH0623113B2
(ja)
|
1986-01-31 |
1994-03-30 |
浩 前田 |
癌性胸・腹水貯留抑制剤
|
|
EP0255011A3
(en)
|
1986-07-29 |
1988-11-23 |
Miles Inc. |
Human inter-alpha-trypsin inhibitor gene
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
JPH0779702B2
(ja)
|
1986-11-17 |
1995-08-30 |
サイオス ノバ インコーポレイテッド |
組換えアルツハイマーアミロイドタンパク
|
|
EP0285123A3
(en)
|
1987-04-03 |
1989-02-01 |
Stabra AG |
A method for complete mutagenesis of nucleic acids
|
|
US5106833A
(en)
|
1987-07-23 |
1992-04-21 |
Washington University |
Coagulation inhibitors
|
|
IL87172A
(en)
|
1987-07-23 |
1994-12-29 |
Univ Washington |
Method of isolating highly purified tissue factor inhibitor
|
|
US4966852A
(en)
|
1987-07-23 |
1990-10-30 |
Monsanto Company |
DNA clone of human tissue factor inhibitor
|
|
GB2208511A
(en)
|
1987-08-07 |
1989-04-05 |
Bayer Ag |
Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
|
|
DK225488D0
(da)
|
1988-04-26 |
1988-04-26 |
Novo Industri As |
Polypeptid
|
|
IL87171A
(en)
|
1987-11-23 |
1995-08-31 |
Monsanto Co |
cDNA of human tissue factor inhibitor
|
|
DE68927933T2
(de)
|
1988-09-02 |
1997-08-14 |
Dyax Corp |
Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US7078383B2
(en)
|
1988-09-02 |
2006-07-18 |
Dyax Corp. |
ITI-D1 Kunitz domain mutants as HNE inhibitors
|
|
US5372933A
(en)
*
|
1988-10-03 |
1994-12-13 |
The Scripps Research Institute |
Polypeptides that mimic receptor-induced binding sites, and methods of using same
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
ATE114332T1
(de)
|
1989-05-13 |
1994-12-15 |
Bayer Ag |
Proteinaseninhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel.
|
|
DK408089D0
(da)
|
1989-08-18 |
1989-08-18 |
Novo Nordisk As |
Proteiner
|
|
US5378614A
(en)
|
1989-08-18 |
1995-01-03 |
Novo Nordisk A/S |
Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
|
|
US5278285A
(en)
|
1990-02-01 |
1994-01-11 |
Bayer Aktiengesellschaft |
Variant of Kunitz-type inhibitor derived from the α3-chain of human type VI collagen produced by recombinant DNA technology
|
|
US5278144A
(en)
|
1990-09-04 |
1994-01-11 |
Cor Therapeutics, Inc. |
Antithrombosis agents
|
|
US5583107A
(en)
|
1990-09-04 |
1996-12-10 |
Cor Therapeutics, Inc. |
Agents affecting thrombosis and hemostasis
|
|
IL99585A0
(en)
|
1990-10-01 |
1992-08-18 |
Novo Nordisk As |
Aprotinin analogues,their production and pharmaceutical compositions containing them
|
|
EP0486001A1
(en)
|
1990-11-13 |
1992-05-20 |
Mochida Pharmaceutical Co., Ltd. |
Recombinant urinary trypsin inhibitor fragments and drug composition
|
|
US20030223977A1
(en)
|
1991-03-01 |
2003-12-04 |
Ley Arthur Charles |
Kunitz domain mutants as cathepsin G inhibitors
|
|
US5166133A
(en)
|
1991-04-17 |
1992-11-24 |
Cetus Corporation |
Method for inhibing adhesion of white blood cells to endothelial cells
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
WO1993009233A2
(en)
|
1991-10-31 |
1993-05-13 |
The Salk Institute Biotechnology/Industrial Associates Inc. |
Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states
|
|
IL104325A
(en)
|
1992-01-07 |
2000-10-31 |
Novo Nordisk As |
Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
|
|
IL104327A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104324A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104326A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104314A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
|
|
US5212091A
(en)
|
1992-03-02 |
1993-05-18 |
Monsanto Company |
Method of producing tissue factor pathway inhibitor
|
|
US6063764A
(en)
|
1992-06-01 |
2000-05-16 |
Washington University & Chiron Corp. |
Method for using lipoprotein associated coagulation inhibitor to treat sepsis
|
|
US5747449A
(en)
*
|
1992-07-13 |
1998-05-05 |
Corvas International, Inc. |
Bovine pancreatic trypsin inhibitor derived inhibitors of factor XA
|
|
US5436153A
(en)
*
|
1992-12-02 |
1995-07-25 |
Sprecher; Cindy A. |
Human amyloid protein precursor homolog and Kunitz-type inhibitor
|
|
IL107831A0
(en)
|
1992-12-02 |
1994-05-30 |
Zymogenetics Inc |
Novel human amyloid protein precursor homolog and kunitz-type inhibitor
|
|
US5426224A
(en)
|
1993-03-18 |
1995-06-20 |
The University Of North Carolina At Chapel Hill |
Mammalian DNA topoisomerase II inhibitor and method
|
|
CA2170030A1
(en)
|
1993-09-14 |
1995-03-23 |
Robert A. Lazarus |
Pharmaceutical compositions containing ecotin and homologs thereof
|
|
US5455338A
(en)
|
1993-11-05 |
1995-10-03 |
Zymogenetics, Inc. |
DNA encoding novel human kunitz-type inhibitors and methods relating thereto
|
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
US5759548A
(en)
|
1993-11-30 |
1998-06-02 |
Lxr Biotechnology Inc. |
Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
CA2180950C
(en)
|
1994-01-11 |
2005-03-29 |
William Markland |
Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
|
|
EP0737207B1
(en)
|
1994-01-11 |
2004-09-22 |
Dyax Corporation |
Inhibitors of human plasmin derived from the kunitz domains
|
|
US6057287A
(en)
|
1994-01-11 |
2000-05-02 |
Dyax Corp. |
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
|
|
US5795954A
(en)
*
|
1994-03-04 |
1998-08-18 |
Genentech, Inc. |
Factor VIIa inhibitors from Kunitz domain proteins
|
|
AU690986B2
(en)
|
1994-06-02 |
1998-05-07 |
Merrell Pharmaceuticals Inc. |
Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
|
|
US5589359A
(en)
|
1994-08-05 |
1996-12-31 |
Chiron Corporation |
Chimeric proteins
|
|
AU707762B2
(en)
|
1994-08-05 |
1999-07-22 |
Novartis Vaccines And Diagnostics, Inc. |
Production of tissue factor pathway inhibitor
|
|
US5648331A
(en)
|
1994-08-26 |
1997-07-15 |
G.D. Searle & Co. |
Method of inhibiting tissue ischemia and reperfusion injury
|
|
US6090916A
(en)
*
|
1994-10-18 |
2000-07-18 |
Corvas International, Inc. |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
|
US6159938A
(en)
*
|
1994-11-21 |
2000-12-12 |
Cortech, Inc. |
Serine protease inhibitors comprising α-keto heterocycles
|
|
AU4467396A
(en)
*
|
1994-12-12 |
1996-07-10 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain, inflammation and spasm
|
|
RU2180852C2
(ru)
*
|
1994-12-12 |
2002-03-27 |
Омерос Медикл Системс, Инк. |
Ингибирующий раствор и способ подавления боли, воспаления или спазма
|
|
US5914316A
(en)
|
1994-12-16 |
1999-06-22 |
Washington University |
Method of inhibiting intimal hyperplasia
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
EP0813525B9
(en)
*
|
1995-03-10 |
2004-02-04 |
Berlex Laboratories, Inc. |
Benzamidine derivatives their preparation and their use as anti-coagulants
|
|
US5695760A
(en)
|
1995-04-24 |
1997-12-09 |
Boehringer Inglehiem Pharmaceuticals, Inc. |
Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
|
|
US5804376A
(en)
|
1995-05-02 |
1998-09-08 |
Incyte Pharmaceuticals, Inc. |
Pancreas-derived serpin
|
|
JPH11504938A
(ja)
|
1995-05-08 |
1999-05-11 |
サイオス インク． |
クニッツ型プロテアーゼ阻害因子
|
|
ZA963619B
(en)
|
1995-05-08 |
1996-11-22 |
Scios Inc |
Protease inhibitor peptides
|
|
US5780265A
(en)
*
|
1995-06-05 |
1998-07-14 |
Genentech, Inc. |
Kunitz type plasma kallikrein inhibitors
|
|
US5786328A
(en)
|
1995-06-05 |
1998-07-28 |
Genentech, Inc. |
Use of kunitz type plasma kallikrein inhibitors
|
|
US6242414B1
(en)
|
1995-06-07 |
2001-06-05 |
Chiron Corporation |
Regulation of cytokine synthesis and release
|
|
US6126933A
(en)
|
1995-06-27 |
2000-10-03 |
Genetics Institute |
Methods of treating inflammatory bowel diseases by administering IL-11
|
|
US5672662A
(en)
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
|
JPH0959838A
(ja)
|
1995-08-24 |
1997-03-04 |
Kuraray Co Ltd |
紡績糸
|
|
CN1200036A
(zh)
|
1995-09-14 |
1998-11-25 |
Lxr生物技术有限公司 |
含有磷脂混合物并具有抗细胞程序死亡活性的组合物
|
|
US5853723A
(en)
|
1995-09-21 |
1998-12-29 |
University Of Utah Research Foundation |
Targeting of peg antibody conjugates to islet cells
|
|
US5824870A
(en)
*
|
1995-11-06 |
1998-10-20 |
Baszczynski; Chris |
Commercial production of aprotinin in plants
|
|
US5736364A
(en)
|
1995-12-04 |
1998-04-07 |
Genentech, Inc. |
Factor viia inhibitors
|
|
WO1997033996A2
(en)
|
1996-03-11 |
1997-09-18 |
Bayer Corporation |
Human bikunin
|
|
US6013763A
(en)
*
|
1996-06-04 |
2000-01-11 |
Genentech, Inc. |
Peptide variants of protein A
|
|
US5869637A
(en)
|
1996-07-22 |
1999-02-09 |
Incyte Pharmaceuticals, Inc. |
Human Kallikrein
|
|
US6214966B1
(en)
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
|
US6255455B1
(en)
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
|
US6258351B1
(en)
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
|
AU6042298A
(en)
|
1997-01-31 |
1998-08-25 |
Human Genome Sciences, Inc. |
Tissue factor pathway inhibitor-3
|
|
US5962300A
(en)
|
1997-03-26 |
1999-10-05 |
Incyte Pharmaceuticals, Inc. |
Human kallikrein
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
US5990237A
(en)
|
1997-05-21 |
1999-11-23 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
|
|
AU734734B2
(en)
|
1997-10-28 |
2001-06-21 |
Vivus, Inc. |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
ES2211033T3
(es)
|
1998-01-07 |
2004-07-01 |
Debio Recherche Pharmaceutique S.A. |
Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos.
|
|
CA2323048C
(en)
|
1998-03-12 |
2006-10-10 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) derivatives with proximal reactive groups
|
|
US6455639B1
(en)
|
1998-03-24 |
2002-09-24 |
Nof Corporation |
Oxirane derivative and process for the preparation thereof
|
|
US6017723A
(en)
|
1998-03-27 |
2000-01-25 |
Long Island Jewish Medical Center |
Method for isolating inhibitors of protease activity
|
|
US6001596A
(en)
|
1998-05-07 |
1999-12-14 |
Incyte Pharmaceuticals, Inc. |
Growth-associated protease inhibitor heavy chain precursor
|
|
US6087473A
(en)
*
|
1999-05-26 |
2000-07-11 |
Zymogenetics, Inc. |
Kunitz domain polypeptide and materials and methods for making it
|
|
CA2330191A1
(en)
|
1998-06-03 |
1999-12-09 |
Scios, Inc. |
Protease inhibitor peptides
|
|
US6783965B1
(en)
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
|
ATE298251T1
(de)
|
1998-08-06 |
2005-07-15 |
Mountain View Pharmaceuticals |
Peg-uricase konjugate und verwendung davon
|
|
CA2342072C
(en)
|
1998-09-03 |
2005-01-11 |
Zymogenetics, Inc. |
Kunitz domain polypeptide zkun6
|
|
US7067144B2
(en)
|
1998-10-20 |
2006-06-27 |
Omeros Corporation |
Compositions and methods for systemic inhibition of cartilage degradation
|
|
US6565874B1
(en)
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
|
JP2002531089A
(ja)
|
1998-11-30 |
2002-09-24 |
イーライ・リリー・アンド・カンパニー |
赤血球産生性化合物
|
|
AU776910B2
(en)
|
1998-12-08 |
2004-09-23 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Modifying protein immunogenicity
|
|
US20030012969A1
(en)
|
1999-04-06 |
2003-01-16 |
Clark Bert Thomas |
Soluble membrane strengthened paper products
|
|
EP1178821B1
(en)
*
|
1999-04-29 |
2005-12-14 |
Novo Nordisk A/S |
Use of anti-hbp antibodies in the inhibition of bradykinin release
|
|
US6605316B1
(en)
|
1999-07-31 |
2003-08-12 |
The Regents Of The University Of California |
Structures and fabrication techniques for solid state electrochemical devices
|
|
US6180607B1
(en)
|
1999-08-05 |
2001-01-30 |
Christopher Davies |
Protein having proteinase inhibitor activity
|
|
NZ517202A
(en)
|
1999-08-24 |
2004-05-28 |
Medarex Inc |
Human CTLA-4 antibodies and their uses
|
|
JP2003513681A
(ja)
|
1999-11-12 |
2003-04-15 |
マキシゲン・ホールディングス・リミテッド |
インターフェロンガンマ・コンジュゲート
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
US6544760B2
(en)
|
1999-12-22 |
2003-04-08 |
Zymogenetics, Inc. |
Kunitz domain polypeptide Zkun11
|
|
PT1259563E
(pt)
|
1999-12-22 |
2009-04-14 |
Nektar Therapeutics Al Corp |
Processo para a preparação de ésteres de 1-benzotriazolil- -carbonato de polímeros solúveis em água
|
|
US6413507B1
(en)
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
|
US20020102703A1
(en)
|
1999-12-29 |
2002-08-01 |
Sheppard Paul O. |
Kunitz domain polypeptide zkun10
|
|
GB9930882D0
(en)
*
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
|
WO2001068707A1
(en)
|
2000-03-13 |
2001-09-20 |
Eli Lilly And Company |
Human hepatocyte growth factor activator inhibitor homologue
|
|
US6926898B2
(en)
*
|
2000-04-12 |
2005-08-09 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
CN1331213A
(zh)
|
2000-06-30 |
2002-01-16 |
上海博德基因开发有限公司 |
一种新的多肽——人大蛋白10.01和编码这种多肽的多核苷酸
|
|
DE10034357C1
(de)
|
2000-07-14 |
2001-12-13 |
Elotherm Gmbh |
Verfahren und Vorrichtung zum Härten von Flächen an Bauteilen
|
|
ATE549347T1
(de)
|
2000-09-08 |
2012-03-15 |
Schering Corp |
Gene von säugetiere, und damit verbundene reagentien, methoden
|
|
ATE245445T1
(de)
|
2000-10-31 |
2003-08-15 |
Debiopharm Sa |
Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen
|
|
US20030113726A1
(en)
*
|
2000-12-04 |
2003-06-19 |
Zenta Tsuchihashi |
Human single nucleotide polymorphisms
|
|
TW593427B
(en)
|
2000-12-18 |
2004-06-21 |
Nektar Therapeutics Al Corp |
Synthesis of high molecular weight non-peptidic polymer derivatives
|
|
US20020168323A1
(en)
|
2001-05-11 |
2002-11-14 |
Igor Gonda |
Optimization of the molecular properties and formulation of proteins delivered by inhalation
|
|
KR20030097876A
(ko)
|
2001-05-21 |
2003-12-31 |
넥타르 테라퓨틱스 |
화학적으로 개질된 인슐린의 폐 투여
|
|
US20040152633A1
(en)
|
2001-05-31 |
2004-08-05 |
Jorgensen Marianne Ulrich |
Kunitz-type sequences and polypeptides
|
|
EP1406652A2
(en)
|
2001-07-10 |
2004-04-14 |
Omnio AB |
Novel drug targets for arthritis
|
|
US6926250B1
(en)
|
2001-07-10 |
2005-08-09 |
Sankyo Seiki Mfg. Co., Ltd. |
Valve driving device
|
|
US20060122374A1
(en)
*
|
2002-02-07 |
2006-06-08 |
Peter Mertins |
Albumin-fused anti-angiogenesis peptides
|
|
AU2003231865A1
(en)
|
2002-05-31 |
2003-12-19 |
Genzyme Corporation |
Alpha acyloxyacetamides for kallikrein and urokinase inhibition
|
|
US7153829B2
(en)
*
|
2002-06-07 |
2006-12-26 |
Dyax Corp. |
Kallikrein-inhibitor therapies
|
|
PT2298278E
(pt)
*
|
2002-06-07 |
2016-02-25 |
Dyax Corp |
Prevenção e redução da perda de sangue e resposta inflamatória
|
|
CN100337689C
(zh)
|
2002-07-24 |
2007-09-19 |
弗·哈夫曼-拉罗切有限公司 |
聚亚烷基二醇酸加合物
|
|
BR0312889A
(pt)
|
2002-07-24 |
2005-06-14 |
Hoffmann La Roche |
Polipeptìdeo t20 peguilado
|
|
WO2004019968A1
(en)
*
|
2002-08-28 |
2004-03-11 |
Dyax Corp. |
Methods for preserving organs and tissues
|
|
US8129330B2
(en)
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
US7314613B2
(en)
|
2002-11-18 |
2008-01-01 |
Maxygen, Inc. |
Interferon-alpha polypeptides and conjugates
|
|
GEP20084486B
(en)
|
2002-12-26 |
2008-09-25 |
Mountain View Pharmaceuticals |
Polymer conjugates of interferon-beta with enhanced biological potency
|
|
PT1587907E
(pt)
|
2003-01-07 |
2011-04-08 |
Dyax Corp |
Biblioteca de domínios de kunitz
|
|
PT1589949E
(pt)
|
2003-01-08 |
2008-11-06 |
Novartis Vaccines & Diagnostic |
Composições liofilizadas estabilizadas compreendendo inibidor da coagulação por factores tecidulares ou variante de inibidor da coagulação por factores tecidulares
|
|
ES2321297T3
(es)
|
2003-01-08 |
2009-06-04 |
Novartis Vaccines And Diagnostics, Inc. |
Composiciones acuosas estabilizadas que comprenden inhibidor de la via del factor tisular (ivft) o variante del inhibidor de la via del factor tisular.
|
|
DE10301300B4
(de)
|
2003-01-15 |
2009-07-16 |
Curacyte Chemistry Gmbh |
Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein
|
|
US6989369B2
(en)
*
|
2003-02-07 |
2006-01-24 |
Dyax Corp. |
Kunitz domain peptides
|
|
US20060205671A1
(en)
|
2003-07-02 |
2006-09-14 |
Jakob Vinten-Johansen |
Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury
|
|
EP1660537A2
(en)
|
2003-08-14 |
2006-05-31 |
Dyax Corp. |
Endotheliase-2 ligands
|
|
CA3050564A1
(en)
|
2003-08-29 |
2005-03-10 |
Dyax Corp. |
Poly-pegylated protease inhibitors
|
|
CA2537113A1
(en)
|
2003-08-29 |
2005-03-10 |
Dyax Corp. |
Modified protease inhibitors
|
|
WO2005027753A1
(en)
|
2003-09-19 |
2005-03-31 |
St. Jude Medical, Inc. |
Apparatus and methods for tissue gathering and securing
|
|
CA2540895C
(en)
|
2003-10-02 |
2016-08-02 |
Elan Pharmaceuticals, Inc. |
Combinations of ziconotide and opioids for reducing pain
|
|
US20060228331A1
(en)
|
2003-10-10 |
2006-10-12 |
Novo Nordisk A/S |
IL-21 Derivatives and variants
|
|
WO2005041631A2
(en)
|
2003-10-21 |
2005-05-12 |
Dyax Corp. |
Endotheliase-1 ligands
|
|
EP1713929A2
(en)
|
2004-02-03 |
2006-10-25 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
|
|
CA2575791A1
(en)
|
2004-08-03 |
2006-02-16 |
Dyax Corp. |
Hk1-binding proteins
|
|
US7235530B2
(en)
*
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
|
WO2006057997A2
(en)
|
2004-11-22 |
2006-06-01 |
Dyax Corp. |
Plasmin-inhibitory therapies
|
|
CN101102819A
(zh)
|
2004-12-23 |
2008-01-09 |
Csl百灵有限公司 |
血栓的形成和/或稳定化的预防
|
|
US20060183771A1
(en)
|
2005-02-17 |
2006-08-17 |
Seiffert Dietmar A |
Novel combination of selective factor VIIa and/or factor XIa inhibitors and selective plasma kallikrein inhibitors
|
|
DE602006020123D1
(de)
|
2005-05-04 |
2011-03-31 |
Zealand Pharma As |
Glucagon-like-peptide-2- (glp-2-) analoga
|
|
US20070079096A1
(en)
|
2005-09-30 |
2007-04-05 |
Chih-Wei Chen |
Data storage unit access authorization table automatic rebuilding method and system
|
|
EP1981519B1
(en)
|
2005-12-29 |
2017-12-27 |
Dyax Corp. |
Protease inhibition
|
|
US7276480B1
(en)
*
|
2005-12-30 |
2007-10-02 |
Dyax Corp. |
Prevention and reduction of blood loss
|
|
US20070213275A1
(en)
*
|
2006-03-10 |
2007-09-13 |
Dyax Corp. |
Formulations for ecallantide
|
|
DK1854477T3
(en)
|
2006-03-16 |
2016-11-28 |
Dyax Corp |
Peptide inhibitors of plasma kallikrein for use in the treatment of eye disorders
|
|
US20080031426A1
(en)
|
2006-06-27 |
2008-02-07 |
Weeks Walter L |
Audio, video, and navigational law enforcement system and method
|
|
EP1873344A1
(de)
|
2006-06-30 |
2008-01-02 |
Sika Technology AG |
Mittels Silikon agedichtete Verklebung
|
|
EP2051707B1
(en)
|
2006-07-31 |
2013-07-17 |
Activesite Pharmaceuticals, Inc. |
Inhibitors of plasma kallikrein
|
|
WO2008060764A2
(en)
|
2006-10-05 |
2008-05-22 |
Drugtech Corporation |
Topical therapies for oral mucositis and other conditions
|
|
WO2009026334A2
(en)
|
2007-08-21 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
|
WO2009026539A1
(en)
|
2007-08-23 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
|
EP2245153A4
(en)
|
2008-02-13 |
2011-06-22 |
Dyax Corp |
IMPROVED METHODS FOR PRODUCING SPECIFIC BINDING SAVINGS
|
|
DE102008027574A1
(de)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
|
|
DE102008033095A1
(de)
|
2008-07-15 |
2010-01-28 |
Uhde Gmbh |
Vorrichtung zur Schlackeabführung aus einem Kohlevergasungsreaktor
|
|
JP2013516389A
(ja)
|
2009-01-06 |
2013-05-13 |
ダイアックス コーポレーション |
カリクレイン阻害剤による粘膜炎治療
|
|
ES2905545T3
(es)
|
2010-01-06 |
2022-04-11 |
Takeda Pharmaceuticals Co |
Proteínas de unión a calicreína plasmática
|
|
KR102011156B1
(ko)
|
2011-01-06 |
2019-08-16 |
다이액스 코포레이션 |
혈장 칼리크레인 결합 단백질
|